Liquidata Share/ETF/Trust Analysis
Portfolio Holdings Detail for ISIN IE00BF4RFH31
| Stock Name / Fund | iShares MSCI World Small Cap UCITS ETF USD (Acc) |
| Issuer | Blackrock |
| Entity holding fund | iShares III Public Limited Company |
| Entity Type | Umbrella investment company with variable capital and having segregated liability between its funds |
| Entity LEI | 549300PZLRJB7M8H1057 |
| ETF Ticker | WSML(USD) LSE |
| ETF Ticker | WLDS(GBP) LSE |
| ETF Ticker | IUSN(EUR) F |
| ETF Ticker | IUSN.DE(EUR) CXE |
| ETF Ticker | WLDS.LS(GBP) CXE |
| ETF Ticker | WSML.LS(USD) CXE |
| ETF Ticker | WSML.L(GBP) LSE |
| ETF Ticker | WLDS.L(GBP) LSE |
Holdings detail for AVXL
| Stock Name | Anavex Life Sciences Corp |
| Ticker | AVXL(USD) NASDAQ |
| TYPE | Common Stock |
| Country | USA |
| ISIN | US0327973006 |
| LEI | 549300K1I5L8COCQ8W36 |
Show aggregate AVXL holdings
News associated with AVXL
- D. Boral Capital Reiterates Buy Rating for Anavex Life Sciences (NASDAQ:AVXL)
- Anavex Life Sciences (NASDAQ:AVXL – Get Free Report)‘s stock had its “buy” rating restated by research analysts at D. Boral Capital in a research report issued on Wednesday,Benzinga reports. They presently have a $46.00 price objective on the biotechnology company’s stock. D. Boral Capital’s price objective indicates a potential upside of 380.17% from the company’s […] - 2025-09-12 03:00:45
- Anavex Life Sciences (NASDAQ:AVXL) Receives Buy Rating from HC Wainwright
- HC Wainwright reissued their buy rating on shares of Anavex Life Sciences (NASDAQ:AVXL – Free Report) in a report released on Wednesday morning,Benzinga reports. They currently have a $42.00 target price on the biotechnology company’s stock. Other research analysts have also issued research reports about the stock. Wall Street Zen lowered shares of Anavex Life […] - 2025-09-11 04:46:19
- Anavex Life Sciences (NASDAQ:AVXL) Given “Buy” Rating at HC Wainwright
- HC Wainwright reiterated their buy rating on shares of Anavex Life Sciences (NASDAQ:AVXL – Free Report) in a research report sent to investors on Friday morning,Benzinga reports. The firm currently has a $42.00 price target on the biotechnology company’s stock. Separately, D. Boral Capital reaffirmed a “buy” rating and issued a $46.00 price target on […] - 2025-08-25 02:12:48
- Sheaff Brock Investment Advisors LLC Sells 4,500 Shares of Anavex Life Sciences Corp. (NASDAQ:AVXL)
- Sheaff Brock Investment Advisors LLC decreased its stake in Anavex Life Sciences Corp. (NASDAQ:AVXL – Free Report) by 28.6% during the first quarter, Holdings Channel.com reports. The institutional investor owned 11,250 shares of the biotechnology company’s stock after selling 4,500 shares during the quarter. Sheaff Brock Investment Advisors LLC’s holdings in Anavex Life Sciences were […] - 2025-07-30 05:17:01
- Arizona State Retirement System Takes $208,000 Position in Anavex Life Sciences Corp. (NASDAQ:AVXL)
- Arizona State Retirement System acquired a new position in Anavex Life Sciences Corp. (NASDAQ:AVXL – Free Report) in the first quarter, according to its most recent Form 13F filing with the SEC. The institutional investor acquired 24,297 shares of the biotechnology company’s stock, valued at approximately $208,000. A number of other institutional investors and hedge […] - 2025-07-23 04:54:53
- Alps Advisors Inc. Sells 8,346 Shares of Anavex Life Sciences Corp. (NASDAQ:AVXL)
- Alps Advisors Inc. cut its holdings in Anavex Life Sciences Corp. (NASDAQ:AVXL – Free Report) by 12.2% during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 60,220 shares of the biotechnology company’s stock after selling 8,346 shares during the quarter. Alps Advisors Inc.’s […] - 2025-07-15 06:26:00
- Critical Survey: Anavex Life Sciences (NASDAQ:AVXL) & Beyond Air (NASDAQ:XAIR)
- Beyond Air (NASDAQ:XAIR – Get Free Report) and Anavex Life Sciences (NASDAQ:AVXL – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their valuation, institutional ownership, analyst recommendations, profitability, earnings, dividends and risk. Valuation & Earnings This table compares […] - 2025-07-14 02:41:00
- Cetera Investment Advisers Takes $150,000 Position in Anavex Life Sciences Corp. (NASDAQ:AVXL)
- Cetera Investment Advisers bought a new stake in Anavex Life Sciences Corp. (NASDAQ:AVXL – Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 14,001 shares of the biotechnology company’s stock, valued at approximately $150,000. Several other hedge […] - 2025-06-03 06:22:58
- Squarepoint Ops LLC Boosts Stock Holdings in Anavex Life Sciences Corp. (NASDAQ:AVXL)
- Squarepoint Ops LLC raised its holdings in shares of Anavex Life Sciences Corp. (NASDAQ:AVXL – Free Report) by 304.9% during the fourth quarter, according to its most recent filing with the SEC. The firm owned 67,627 shares of the biotechnology company’s stock after purchasing an additional 50,924 shares during the period. Squarepoint Ops LLC owned […] - 2025-06-03 05:38:51
- Bank of America Corp DE Has $2.14 Million Stock Position in Anavex Life Sciences Corp. (NASDAQ:AVXL)
- Bank of America Corp DE cut its stake in Anavex Life Sciences Corp. (NASDAQ:AVXL – Free Report) by 27.8% in the 4th quarter, HoldingsChannel.com reports. The firm owned 198,780 shares of the biotechnology company’s stock after selling 76,485 shares during the quarter. Bank of America Corp DE’s holdings in Anavex Life Sciences were worth $2,135,000 […] - 2025-06-03 05:04:52
- MetLife Investment Management LLC Has $496,000 Holdings in Anavex Life Sciences Corp. (NASDAQ:AVXL)
- MetLife Investment Management LLC grew its holdings in shares of Anavex Life Sciences Corp. (NASDAQ:AVXL – Free Report) by 14.4% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 46,177 shares of the biotechnology company’s stock after acquiring an additional 5,816 […] - 2025-05-06 05:01:07
- AlphaQuest LLC Acquires Shares of 13,626 Anavex Life Sciences Corp. (NASDAQ:AVXL)
- AlphaQuest LLC acquired a new stake in shares of Anavex Life Sciences Corp. (NASDAQ:AVXL – Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor acquired 13,626 shares of the biotechnology company’s stock, valued at approximately $146,000. Several other hedge funds and […] - 2025-03-18 06:06:52
- 19,558 Shares in Anavex Life Sciences Corp. (NASDAQ:AVXL) Bought by Proficio Capital Partners LLC
- Proficio Capital Partners LLC bought a new position in shares of Anavex Life Sciences Corp. (NASDAQ:AVXL – Free Report) in the fourth quarter, HoldingsChannel.com reports. The institutional investor bought 19,558 shares of the biotechnology company’s stock, valued at approximately $210,000. Several other hedge funds and other institutional investors have also recently modified their holdings of […] - 2025-03-13 05:14:57
- Y Intercept Hong Kong Ltd Buys New Position in Anavex Life Sciences Corp. (NASDAQ:AVXL)
- Y Intercept Hong Kong Ltd purchased a new position in Anavex Life Sciences Corp. (NASDAQ:AVXL – Free Report) during the 4th quarter, HoldingsChannel reports. The firm purchased 22,631 shares of the biotechnology company’s stock, valued at approximately $243,000. Other large investors also recently made changes to their positions in the company. Barclays PLC lifted its […] - 2025-03-05 08:19:04
- Anavex Life Sciences (NASDAQ:AVXL) vs. Cortexyme (NASDAQ:CRTX) Financial Survey
- Anavex Life Sciences (NASDAQ:AVXL – Get Free Report) and Cortexyme (NASDAQ:CRTX – Get Free Report) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, risk, institutional ownership, valuation, analyst recommendations, dividends and profitability. Valuation & Earnings This table compares Anavex […] - 2025-02-28 05:00:47
- HC Wainwright Reiterates Buy Rating for Anavex Life Sciences (NASDAQ:AVXL)
- Anavex Life Sciences (NASDAQ:AVXL – Get Free Report)‘s stock had its “buy” rating reaffirmed by research analysts at HC Wainwright in a research note issued to investors on Tuesday,Benzinga reports. They presently have a $42.00 price target on the biotechnology company’s stock. HC Wainwright’s price objective would indicate a potential upside of 382.48% from the […] - 2025-02-20 05:14:43
- Anavex Life Sciences Corp. (NASDAQ:AVXL) Shares Purchased by China Universal Asset Management Co. Ltd.
- China Universal Asset Management Co. Ltd. boosted its holdings in shares of Anavex Life Sciences Corp. (NASDAQ:AVXL – Free Report) by 10.2% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 17,980 shares of the biotechnology company’s stock after acquiring […] - 2025-02-04 07:46:55
- SG Americas Securities LLC Has $374,000 Position in Anavex Life Sciences Corp. (NASDAQ:AVXL)
- SG Americas Securities LLC lifted its stake in Anavex Life Sciences Corp. (NASDAQ:AVXL – Free Report) by 25.8% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 34,844 shares of the biotechnology company’s stock after buying an additional 7,138 shares during the period. […] - 2025-02-04 06:55:00
iShares MSCI World Small Cap UCITS ETF USD (Acc) AVXL holdings
| Date | Number of AVXL Shares Held | Base Market Value of AVXL Shares | Local Market Value of AVXL Shares | Change in AVXL Shares Held | Change in AVXL Base Value | Current Price per AVXL Share Held | Previous Price per AVXL Share Held |
|---|
| 2025-10-15 (Wednesday) | 57,678 | USD 520,832 | USD 520,832 | | | | |
| 2025-10-10 (Friday) | 57,300 | USD 531,171 | USD 531,171 | | | | |
| 2025-10-08 (Wednesday) | 57,300 | USD 564,405 | USD 564,405 | | | | |
| 2025-10-07 (Tuesday) | 57,300 | USD 560,394 | USD 560,394 | 248 | USD 12,124 | USD 9.78 | USD 9.61001 |
| 2025-10-06 (Monday) | 57,052 | USD 548,270 | USD 548,270 | 0 | USD -19,968 | USD 9.61001 | USD 9.96 |
| 2025-10-03 (Friday) | 57,052 | USD 568,238 | USD 568,238 | 0 | USD 47,353 | USD 9.96 | USD 9.13 |
| 2025-10-02 (Thursday) | 57,052 | USD 520,885 | USD 520,885 | 0 | USD 6,846 | USD 9.13 | USD 9.01001 |
| 2025-10-01 (Wednesday) | 57,052 | USD 514,039 | USD 514,039 | 0 | USD 6,276 | USD 9.01001 | USD 8.9 |
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdingsShare Trades of AVXL by Blackrock for IE00BF4RFH31
Show aggregate share trades of AVXL| Date | Action | Quantity | Market High | Market Low | Likely Trade Price | Likely Trade Value (Profit/Loss) | Average Price previous trades |
|---|
| 2025-10-07 | BUY | 248 | | | 9.780* | | 9.05 |
| 2025-09-08 | SELL | -496 | | | 9.350* | | 9.05 Profit of 4,489 on sale |
| 2025-08-15 | BUY | 244 | | | 9.945* | | 9.04 |
| 2025-07-14 | BUY | 492 | | | 11.480* | | 8.81 |
| 2025-06-30 | BUY | 496 | | | 9.220* | | 8.67 |
| 2025-06-25 | BUY | 744 | | | 9.410* | | 8.64 |
| 2025-06-20 | SELL | -126 | | | 9.090* | | 8.62 Profit of 1,086 on sale |
| 2025-06-12 | SELL | -1,024 | | | 8.220* | | 8.62 Profit of 8,823 on sale |
| 2025-06-02 | BUY | 390 | | | 7.560* | | 8.70 |
| 2025-05-28 | BUY | 258 | | | 7.580* | | 8.76 |
| 2025-05-14 | BUY | 126 | | | 8.170* | | 8.94 |
| 2025-05-13 | BUY | 252 | | | 8.120* | | 8.95 |
| 2025-05-07 | BUY | 375 | | | 8.480* | | 9.00 |
| 2025-04-28 | BUY | 124 | | | 9.580* | | 8.96 |
| 2025-04-16 | BUY | 1,638 | | | 8.840* | | 8.92 |
| 2025-04-14 | BUY | 250 | | | 8.820* | | 8.91 |
| 2025-04-08 | SELL | -252 | | | 7.600* | | 8.99 Profit of 2,267 on sale |
| 2025-04-04 | SELL | -258 | | | 8.190* | | 9.06 Profit of 2,338 on sale |
| 2025-03-28 | BUY | 1,260 | | | 8.720* | | 9.19 |
| 2025-03-12 | SELL | -254 | | | 8.900* | | 8.67 Profit of 2,203 on sale |
| 2025-03-07 | BUY | 9,035 | | | 8.670* | | 8.47 |
| 2025-03-05 | BUY | 897 | | | 8.730* | | 8.34 |
| 2025-03-04 | BUY | 499 | | | 8.410* | | 8.27 |
| 2025-03-03 | BUY | 1,750 | | | 8.270* | | 0.00 |
Market high and low price is on the date. * (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection
The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close
Shorting History of AVXL
| Date | Shorted Volume | Short Exempt Volume | Total Shares Traded | % Shorted |
|---|
| 2025-09-19 | 292,950 | 350 | 493,091 | 59.4% |
| 2025-09-18 | 292,461 | 730 | 632,664 | 46.2% |
| 2025-09-17 | 238,968 | 0 | 344,719 | 69.3% |
| 2025-09-16 | 124,131 | 0 | 203,931 | 60.9% |
| 2025-09-15 | 327,284 | 620 | 495,734 | 66.0% |
| 2025-09-12 | 188,856 | 9 | 297,912 | 63.4% |
| 2025-09-11 | 283,057 | 43,129 | 512,801 | 55.2% |
| 2025-09-10 | 755,725 | 40,238 | 1,047,179 | 72.2% |
| 2025-09-09 | 651,589 | 1,000 | 1,103,832 | 59.0% |
| 2025-09-08 | 191,294 | 0 | 265,507 | 72.0% |
| 2025-09-05 | 130,504 | 50 | 260,693 | 50.1% |
| 2025-09-04 | 258,462 | 0 | 360,127 | 71.8% |
| 2025-09-03 | 237,765 | 2,728 | 362,191 | 65.6% |
| 2025-09-02 | 249,450 | 100 | 378,631 | 65.9% |
| 2025-08-29 | 238,966 | 375 | 388,448 | 61.5% |
| 2025-08-28 | 209,977 | 2,300 | 320,987 | 65.4% |
| 2025-08-27 | 232,736 | 0 | 330,617 | 70.4% |
| 2025-08-26 | 104,349 | 1,056 | 307,622 | 33.9% |
| 2025-08-25 | 205,172 | 2,500 | 283,898 | 72.3% |
| 2025-08-22 | 168,634 | 0 | 247,739 | 68.1% |
| 2025-08-21 | 193,437 | 1,834 | 320,019 | 60.4% |
| 2025-08-20 | 170,915 | 0 | 218,615 | 78.2% |
| 2025-08-19 | 281,852 | 19,391 | 450,833 | 62.5% |
| 2025-08-18 | 254,587 | 432 | 358,911 | 70.9% |
| 2025-08-15 | 282,594 | 80,843 | 392,702 | 72.0% |
| 2025-08-14 | 327,006 | 9,894 | 473,515 | 69.1% |
| 2025-08-13 | 310,944 | 1,019 | 479,075 | 64.9% |
| 2025-08-12 | 518,863 | 2,020 | 696,657 | 74.5% |
| 2025-08-11 | 223,214 | 0 | 368,082 | 60.6% |
| 2025-08-08 | 207,053 | 2,314 | 312,375 | 66.3% |
| 2025-08-07 | 265,030 | 12,385 | 393,458 | 67.4% |
| 2025-08-06 | 153,741 | 721 | 216,786 | 70.9% |
| 2025-08-05 | 243,764 | 2,107 | 326,215 | 74.7% |
| 2025-08-04 | 252,173 | 0 | 402,479 | 62.7% |
| 2025-08-01 | 247,327 | 210 | 384,957 | 64.2% |
| 2025-07-31 | 461,281 | 2,762 | 698,484 | 66.0% |
| 2025-07-30 | 225,848 | 423 | 354,251 | 63.8% |
| 2025-07-29 | 188,747 | 0 | 337,746 | 55.9% |
| 2025-07-28 | 548,153 | 3,543 | 1,342,139 | 40.8% |
| 2025-07-25 | 366,868 | 27,091 | 609,405 | 60.2% |
| 2025-07-24 | 949,021 | 1,733 | 1,541,426 | 61.6% |
| 2025-07-23 | 830,143 | 3,752 | 1,267,314 | 65.5% |
| 2025-07-22 | 156,882 | 807 | 309,603 | 50.7% |
| 2025-07-21 | 172,877 | 1,716 | 267,374 | 64.7% |
| 2025-07-18 | 196,465 | 1,022 | 268,450 | 73.2% |
The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.
Back to Listing
Disclaimer
All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.